TY - JOUR
T1 - Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer: Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference
AU - Lynch, Seodhna M.
AU - Heeran, Aisling B.
AU - Burke, Caoimbhe
AU - Lynam-Lennon, Niamh
AU - Eustace, Alex J.
AU - Dean, Kellie
AU - Robson, Tracy
AU - Rahman, Arman
AU - Marcone, Simone
N1 - Publisher Copyright:
© 2024 by the authors.
PY - 2024/5/23
Y1 - 2024/5/23
N2 - Advancements in oncology, especially with the era of precision oncology, is resulting in a paradigm shift in cancer care. Indeed, innovative technologies, such as artificial intelligence, are paving the way towards enhanced diagnosis, prevention, and personalised treatments as well as novel drug discoveries. Despite excellent progress, the emergence of resistant cancers has curtailed both the pace and extent to which we can advance. By combining both their understanding of the fundamental biological mechanisms and technological advancements such as artificial intelligence and data science, cancer researchers are now beginning to address this. Together, this will revolutionise cancer care, by enhancing molecular interventions that may aid cancer prevention, inform clinical decision making, and accelerate the development of novel therapeutic drugs. Here, we will discuss the advances and approaches in both artificial intelligence and precision oncology, presented at the 59th Irish Association for Cancer Research annual conference.
AB - Advancements in oncology, especially with the era of precision oncology, is resulting in a paradigm shift in cancer care. Indeed, innovative technologies, such as artificial intelligence, are paving the way towards enhanced diagnosis, prevention, and personalised treatments as well as novel drug discoveries. Despite excellent progress, the emergence of resistant cancers has curtailed both the pace and extent to which we can advance. By combining both their understanding of the fundamental biological mechanisms and technological advancements such as artificial intelligence and data science, cancer researchers are now beginning to address this. Together, this will revolutionise cancer care, by enhancing molecular interventions that may aid cancer prevention, inform clinical decision making, and accelerate the development of novel therapeutic drugs. Here, we will discuss the advances and approaches in both artificial intelligence and precision oncology, presented at the 59th Irish Association for Cancer Research annual conference.
KW - Irish Association for Cancer Research
KW - early detection
KW - targeted therapeutics
KW - emerging hallmarks
KW - artificial intelligence
KW - data science
KW - precision oncology
UR - http://www.scopus.com/inward/record.url?scp=85196091676&partnerID=8YFLogxK
U2 - 10.3390/cancers16111989
DO - 10.3390/cancers16111989
M3 - Conference article
C2 - 38893110
SN - 2072-6694
VL - 16
SP - 1
EP - 22
JO - Cancers
JF - Cancers
IS - 11
M1 - 1989
ER -